Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2025-11-10 2025-11-10
Drug Identification Number 02552035 02552035
Brand name COMIRNATY COMIRNATY
Common or Proper name Comirnaty Comirnaty
Company Name BIONTECH MANUFACTURING GMBH BIONTECH MANUFACTURING GMBH
Ingredients *SARSCOV2 S-PROTEIN MRNA, 5'[M27,3'-OGPPP *SARSCOV2 S-PROTEIN MRNA, 5'[M27,3'-OGPPP
Strength(s) 30MCG 30MCG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 Pre-filled syringe/Carton 1 Pre-filled syringe/Carton
ATC code J07BN J07BN
ATC description
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2025-11-07 2025-11-07
Actual start date
Estimated end date 2025-11-28 2025-11-28
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments On allocation. Other pre-filled syringe pack size available, please communicate with your distributor. On allocation. Other pre-filled syringe pack size available, please communicate with your distributor.
Health Canada comments